These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33805830)

  • 1. Excipients in the Paediatric Population: A Review.
    Rouaz K; Chiclana-Rodríguez B; Nardi-Ricart A; Suñé-Pou M; Mercadé-Frutos D; Suñé-Negre JM; Pérez-Lozano P; García-Montoya E
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33805830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The STEP (Safety and Toxicity of Excipients for Paediatrics) database: part 2 - the pilot version.
    Salunke S; Brandys B; Giacoia G; Tuleu C
    Int J Pharm; 2013 Nov; 457(1):310-22. PubMed ID: 24070789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orally disintegrating mini-tablets (ODMTs)--a novel solid oral dosage form for paediatric use.
    Stoltenberg I; Breitkreutz J
    Eur J Pharm Biopharm; 2011 Aug; 78(3):462-9. PubMed ID: 21324357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compressed orally disintegrating tablets: excipients evolution and formulation strategies.
    Al-khattawi A; Mohammed AR
    Expert Opin Drug Deliv; 2013 May; 10(5):651-63. PubMed ID: 23387409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best practices for selection of excipients for paediatrics - Workshop reflection.
    Salunke S; Clapham D; Agrawal A; Hughes K; Nunn T
    Eur J Pharm Biopharm; 2021 Mar; 160():77-81. PubMed ID: 33400989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
    Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Optimization by Quality by Design Strategies of Frovatriptan Orally Disintegrating Tablets for Migraine Management.
    Mennini N; Orlandini S; Furlanetto S; Pasquini B; Mura P
    Curr Drug Deliv; 2018; 15(3):436-445. PubMed ID: 28595529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The STEP (safety and toxicity of excipients for paediatrics) database. Part 1-A need assessment study.
    Salunke S; Giacoia G; Tuleu C
    Int J Pharm; 2012 Oct; 435(2):101-11. PubMed ID: 22583848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients.
    Walsh J; Cram A; Woertz K; Breitkreutz J; Winzenburg G; Turner R; Tuleu C;
    Adv Drug Deliv Rev; 2014 Jun; 73():14-33. PubMed ID: 24614069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current opinions and recommendations of paediatric healthcare professionals - The importance of tablets: Emerging orally disintegrating versus traditional tablets.
    Alyami H; Koner J; Huynh C; Terry D; Mohammed AR
    PLoS One; 2018; 13(2):e0193292. PubMed ID: 29489871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges and emerging solutions in the development of compressed orally disintegrating tablets.
    Al-Khattawi A; Mohammed AR
    Expert Opin Drug Discov; 2014 Oct; 9(10):1109-20. PubMed ID: 25045997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting orally disintegrating tablets formulations of ibuprophen tablets: an application of the new SeDeM-ODT expert system.
    Aguilar-Díaz JE; García-Montoya E; Suñe-Negre JM; Pérez-Lozano P; Miñarro M; Ticó JR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):638-48. PubMed ID: 22245156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PREPARATION AND CHARACTERIZATION OF ORALLY DISINTEGRATING LORATADINE TABLETS MANUFACTURED WITH CO-PROCESSED MIXTURES.
    Amelian A; Szekalska M; Wilczewska AZ; Basa A; Winnicka K
    Acta Pol Pharm; 2016; 73(2):453-60. PubMed ID: 27180438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Overview of Pharmaceutical Excipients: Safe or Not Safe?
    Abrantes CG; Duarte D; Reis CP
    J Pharm Sci; 2016 Jul; 105(7):2019-26. PubMed ID: 27262205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New orodispersible mini-tablets for paediatric use - A comparison of isomalt with a mannitol based co-processed excipient.
    Lura A; Luhn O; Suarez Gonzales J; Breitkreutz J
    Int J Pharm; 2019 Dec; 572():118804. PubMed ID: 31678381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Use of Magnesium Oxide as an Excipient to Maintain the Hardness of Orally Disintegrating Tablets during Unpackaged Storage.
    Sakamoto T; Kachi S; Nakamura S; Yuasa H
    Chem Pharm Bull (Tokyo); 2019; 67(3):284-288. PubMed ID: 30828006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and evaluation of clozapine orally disintegrating tablets prepared by direct compression.
    Olmez SS; Vural I; Sahin S; Ertugrul A; Capan Y
    Pharmazie; 2013 Feb; 68(2):110-6. PubMed ID: 23469682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spray dried excipient base: a novel technique for the formulation of orally disintegrating tablets.
    Mishra DN; Bindal M; Singh SK; Vijaya Kumar SG
    Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):99-102. PubMed ID: 16394558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical preformulation studies and paediatric oral formulations of sodium dichloroacetate.
    Lopalco A; Curci A; Lopedota A; Cutrignelli A; Laquintana V; Franco M; Denora N
    Eur J Pharm Sci; 2019 Jan; 127():339-350. PubMed ID: 30447284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-Appropriate Formulations Including Pharmaceutical Excipients in Neonatal Medicines.
    Kogermann K; Lass J; Nellis G; Metsvaht T; Lutsar I
    Curr Pharm Des; 2017; 23(38):5779-5789. PubMed ID: 28950820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.